Why Dyne Therapeutics Stock Was Crushing it This Week
One of the healthier stocks over the past several days has been biotech Dyne Therapeutics (NASDAQ: DYN). The company received a positive mention in a broader analyst note on its sector, and investors took this to heart. They traded up the stock to the point where it was 11% higher week-to-date late in Friday's session, according to data compiled by S&P Global Market Intelligence.
That research note was published on Sunday, setting the tone for Dyne (and other mentioned healthcare stocks) for the remainder of the week.
Source Fool.com
